Dr Anthony N Brannan, MD | |
4301 N Habana Ave, Tampa, FL 33607-6546 | |
(813) 879-5010 | |
(813) 443-8148 |
Full Name | Dr Anthony N Brannan |
---|---|
Gender | Male |
Speciality | Colon & Rectal Surgery |
Location | 4301 N Habana Ave, Tampa, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093817454 | NPI | - | NPPES |
0063463-00 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | ME48420 (Florida) | Secondary |
208C00000X | Colon & Rectal Surgery | ME48420 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Anthony N Brannan, MD Po Box 10744, Clearwater, FL 33757-8744 Ph: (727) 532-0002 | Dr Anthony N Brannan, MD 4301 N Habana Ave, Tampa, FL 33607-6546 Ph: (813) 879-5010 |
News Archive
The federal government invested more than $25 billion in health information technology (IT) as a result of the American Reinvestment and Recovery Act; yet, little is known about how IT applications improve patient safety and protect their privacy. Now, a University of Missouri nursing informatics expert suggests that sophisticated IT leads to more robust and integrated communication strategies among clinical staff, which allows staff to more efficiently coordinate care and better protect patient privacy.
In a daring move into the biomedical arena, ITQB chemists from the Molecular Thermodynamics Lab and collaborators from REQUIMTE have managed to convert the solid antibiotic ampicilin into an ionic liquid form, a method that may be extended to other pharmaceutical compounds with benefits for their administration. The work is now published in Medicinal Chemistry Communications.
A study, published in the October issue of the American Journal of Nursing (AJN), revealed that nearly 80% of men are unaware of their breast cancer risk despite having a family history of the disease. One hundred percent of respondents also reported that their healthcare provider did not discuss the disease with them.
Arisaph Pharmaceuticals, Inc. announced today during an oral presentation at the American Heart Association (AHA) meeting in Los Angeles, CA that its niacin analog, ARI-3037MO, was extremely well tolerated in a single-ascending dose (SAD) and a multiple-ascending dose (MAD) trial in healthy male and female volunteers.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago